Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Market In 5 Minutes: Under Armour's Miss, Apple's Q1 Primer

HOG, MA, UPS, VNOM, XOM, S, SHOO, T

Macro Focus

Futures for the Dow Jones Industrial Average tumbled 25 points to 19,863.00, while the Standard & Poor’s 500 index futures fell 2.50 points to 2,273.50. Futures for the Nasdaq 100 index declined 7.50 points to 5,117.00.

Oil prices traded mixed as Brent crude futures gained 0.18 percent to trade at $55.33 per barrel, while US WTI crude futures fell 0.25 percent to trade at $52.50 a barrel.

DJ Redbook: US Retail Sales Up 0.4% vs. Jan. YoY, Down 3.5% MoM, Up 0.2% Week Ended YoY

  • The Federal Open Market Committee will begin its two-day policy meeting today.
  • The Chicago PMI for January will be released at 9:45 a.m. ET.
  • The Conference Board's consumer confidence index for January is schedule for release at 10:00 a.m. ET.
  • Data on farm prices for January will be released at 3:00 p.m. ET.
  • The Treasury is set to auction 4-and 52-week bills at 11:30 a.m. ET.

Bz News Desk Focus

  • Eli Lilly (NYSE: LLY) Reports Q4 EPS $0.95 vs $0.98 Est., Sales $5.761B vs $5.55B Est.
  • Pfizer (NYSE: PFE) Reports Q4 Adj. EPS $0.47 vs $0.50 Est., Sales $13.6B vs $13.63B Est.
  • Under Armour (NYSE: UAA) Reports Q4 EPS $0.23 vs $0.25 Est., Sales $1.3B vs $1.41B Est.
  • Sprint (NYSE: S) Reports Q3 EPS $(0.12), Adj. EBITDA $2.45B, Sales $8.55B vs $8.69B Est.
  • Coach (NYSE: COH) Reports Q2 Adj. EPS $0.75 vs $0.74 Est., Sales $1.32B vs $1.32B Est.
  • Harley-Davidson (NYSE: HOG) Reports Q4 EPS $0.27 vs $0.31 Est., Sales $1.11B vs $972.5M Est.
  • Valero Energy (NYSE: VLO) Reports Q4 EPS $0.81 vs $0.77, Sales $20.712B vs $17.42B Est.
  • UPS (NYSE: UPS) Reports Q4 Adj. EPS $1.63 vs $1.69 Est., Sales $16.931B vs $17B Est.
  • ExxonMobil (NYSE: XOM) Reports Q4 EPS $0.41 vs. Est. $0.70, Rev. $61.01B vs. Est. $62.28B
  • Mastercard (NYSE: MA) Reports Q4 Adj. EPS $0.86 vs $0.85 Est., Sales $2.8B vs $2.79B Est.

Sell-Side's Most Noteworthy Calls

  • Citi upgraded Steven Madden (NASDAQ: SHOO) from Neutral to Buy.
  • Credit Suisse upgraded Viper Energy (NASDAQ: VNOM) from Neutral to Outperform.
  • Roth Capital upgraded xG Technology (NASDAQ: XGTI) from Neutral to Buy
  • Citi downgrades Fitbit (NYSE: FIT) from Neutral to Sell.
  • Summit Redstone downgraded Integrated Device Tech (NASDAQ: IDTI) from Buy to Hold.
  • Jefferies downgraded Natural Grocers (NYSE: NGVC) from Buy to Hold.

Deal Talk

Shares of Time Warner (NYSE: TWX) spiked to a high of $96.95 Monday, following a tweet from Charlie Gasparino that the Trump administration will approve the merger with AT&T (NYSE: T), according to banking sources. CNN could be spunoff or sold to a potential buyer, namely CBS Corporation (NYSE: CBS), sources said. Trump said during the election campaign that he opposed the merger.

Fred's (NASDAQ: FRED) agreed to buy the 200 extra stores agreed upon Monday between Rite Aid (NYSE: RAD) and Walgreens (NASDAQ: WBA). Fred's continues to work with the FTC, Rite Aid and Walgreens to complete the transaction.

In The News

A ballpark hot dog without Kraft Heinz condiments? That’s the All-American experience without foreign-born talent. Some of the most well-known brands in American culture were established by immigrants or their children. So were more than 200 companies on the 2010 Fortune 500 list — a number vastly disproportionate to the ratio of U.S. immigrants to native-born Americans. And the statistics go on and on.

Alzheimer's has proven to be one of the most stubborn diseases known to modern medicine. Susanne Wilke, Ph.D., CEO of Neurotrope (OTC: NTRPD), a biopharmaceutical company with an Alzheimer's treatment called Bryostatin currently in clinical development, described Alzheimer's to Benzinga as "a runaway disease" in a recent interview.

Blogosphere

Iron Ore's Party Is Just Getting Started: "Fortescue Metals Group Ltd. has long been iron ore's greatest cheerleader, and with metal prices near the highest level in two years it's showing no sign of losing faith. Those tempted to discount this as the sort of bullish talk you'd expect from a sales director should take a look at how China's steelmakers are doing from another angle: Blast furnaces in January were the second-most profitable they've been in at least seven years, according to estimates by Bloomberg Intelligence."

Trending

UAA PFE RAD UGA Z COH MAS LLY TEVA CNX AAPL OPB CR AET ABC

Apple (NASDAQ: AAPL), the Goliath of the tech space, is set to release its fiscal Q1 earnings report after the markets close on Tuesday. Sell-side sentiment is divided, with iPhone estimates forming the crux of their deductions, quite understandably, given the roughly two-thirds revenue share of the product. Investors have their fingers crossed. Will Apple taste sweet or will its results sour sentiment toward the stock?



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today